Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -2.84% | +1.65% | -31.48% |
Business Summary
Number of employees: 380
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Tiopronin Products
77.1
%
| 98 | 48.9 % | 98 | 77.1 % | +0.37% |
FILSPARI
22.9
%
| - | - | 29 | 22.9 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 201 | 100.0 % | 128 | 100.0 % | -36.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Dube
CEO | Chief Executive Officer | 51 | 19-01-03 |
Chris Cline
DFI | Director of Finance/CFO | 40 | 14-07-31 |
Jula Inrig
CTO | Chief Tech/Sci/R&D Officer | 49 | 22-01-03 |
Bill Rote
CTO | Chief Tech/Sci/R&D Officer | 61 | 17-01-31 |
Naomi Eichenbaum
IRC | Investor Relations Contact | - | - |
Human Resources Officer | - | - | |
Sandra Calvin
AUD | Comptroller/Controller/Auditor | 59 | 14-11-30 |
Peter Heerma
PRN | Corporate Officer/Principal | 53 | 19-09-30 |
Casey Logan
PRN | Corporate Officer/Principal | 52 | 18-03-04 |
Elizabeth Reed
LAW | General Counsel | 53 | 17-01-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Coughlin
BRD | Director/Board Member | 57 | 15-03-30 |
Jeffrey Meckler
BRD | Director/Board Member | 57 | 14-10-07 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 20-04-07 |
Gary Lyons
CHM | Chairman | 73 | 14-10-08 |
Roy Baynes
BRD | Director/Board Member | 69 | 16-06-30 |
John Orwin
BRD | Director/Board Member | 62 | 17-03-22 |
Ron Squarer
BRD | Director/Board Member | 57 | 17-04-11 |
Sandra E. Poole
BRD | Director/Board Member | 60 | 19-05-12 |
Eric Dube
CEO | Chief Executive Officer | 51 | 19-01-03 |
Sandra Calvin
AUD | Comptroller/Controller/Auditor | 59 | 14-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,129,018 | 75,561,385 ( 99.25 %) | 0 | 99.25 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.48% | 469M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- TVTX Stock
- Company Travere Therapeutics, Inc.